Author: creacionmx

A greater virulent HIV-1 subtype B variant has circulated in The Netherlands since the 1990’s

HIV/AIDS in Pakistan – progress, barriers, and future directions

The RESIST Trials – Superiority of Tipranavir over other Pls

FDA Issues Labeling Changes for Efavirenz

HIV Guidelines

HIV Guidelines

HIV Conferences

Can the Inhibitory Quotient (IQ) be Useful in Clinical Pratice?

Unsafe Medical Procedures are not the Main Route of HIV Infection in Sub-Saharan Africa

Revision of the DHHS Guidelines for the Use of Antiretroviral Agents